Study of what causes and affects lipodystrophy
Part of Hormones & metabolism, Skin clinical trials.
This study observes people with lipodystrophy to better understand how the condition develops and affects the body over time. It may help researchers learn who is most affected and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of lipodystrophy (loss of body fat)
- Your lipodystrophy is due to genetic or acquired causes—not just temporary changes
- You may qualify if you have gene test results showing a disease-causing variant (or supportive clinical findings)
- You have evidence of this condition in how your body looks and/or in related metabolic (blood sugar/fat) problems
- You are not living with HIV
- Your lipodystrophy is not caused by a medication (not drug-induced)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with rare or unusual cholesterol, fat, or heart-related conditions. It helps researchers learn more about these disorders and improve testing. You do not need to have a known diagnosis to join initially.
This study tests a safe way to label fat (triglycerides) in people with a rare condition called familial partial lipodystrophy (FPL), where fat is missing in some areas. It involves two small fat biopsies, one from the belly and one from the thigh, to understand how the body handles fat.
This study looks at how pregnancy goes and what birth outcomes happen in women with lipodystrophy, comparing those who used metreleptin during pregnancy versus those who did not. It also collects information and blood samples from the children so researchers can better understand the effects of metreleptin during pregnancy.
This study follows people who have lymphatic anomalies (lymphatic birthmarks) and sometimes related vascular or genetic conditions. It aims to better understand how these problems develop and what genetic causes may be involved.
This study looks at body chemistry (cholesterol-related lab findings) and physical features in people with Smith-Lemli-Opitz syndrome and related rare genetic cholesterol disorders. It may help researchers better understand these conditions and how they affect the body.
This is a study that keeps a medical record (a registry) of people with lipodystrophy, a condition where body fat is missing or unevenly distributed. It may help researchers understand different causes and patterns of the condition over time.
Hear when a new Lipodystrophy (Genetic or Acquired, Non HIV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.